BRIEF-Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Says Obeticholic Acid Tablets Drug Application Not Approved

Reuters10-13

BRIEF-<a href="https://laohu8.com/S/688505">Shanghai Fudan-Zhangjiang Bio-</a>Pharmaceutical Says Obeticholic Acid Tablets Drug Application Not Approved

Oct 13 (Reuters) - Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd 688505.SS:

NEW DRUG APPLICATION FOR OBETICHOLIC ACID TABLETS WAS NOT APPROVED
NOTIFICATION RECEIVED FROM NATIONAL MEDICAL PRODUCTS ADMINISTRATION OF PRC

Further company coverage: 688505.SS

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2575288016?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-10-13 23:31","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2575288016","market":"fut","top_or_hot":-1,"title":"BRIEF-Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Says Obeticholic Acid Tablets Drug Application Not Approved","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-<a href=\"https://laohu8.com/S/688505\">Shanghai Fudan-Zhangjiang Bio-</a>Pharmaceutical Says Obeticholic Acid Tablets Drug Application Not Approved</title></head><body><p><span>Oct 13 (Reuters)</span><span> - </span><a href=\"https://laohu8.com/S/01385\">Shanghai Fudan</a>-Zhangjiang Bio-Pharmaceutical Co Ltd <span>688505.SS</span>:</p><ul><li><p>NEW DRUG APPLICATION FOR OBETICHOLIC ACID TABLETS WAS NOT APPROVED</p></li><li><p>NOTIFICATION RECEIVED FROM NATIONAL MEDICAL PRODUCTS ADMINISTRATION OF PRC</p></li></ul><p>Further company coverage: <span>688505.SS</span></p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Says Obeticholic Acid Tablets Drug Application Not Approved</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Says Obeticholic Acid Tablets Drug Application Not Approved\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-10-13 23:31</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-<a href=\"https://laohu8.com/S/688505\">Shanghai Fudan-Zhangjiang Bio-</a>Pharmaceutical Says Obeticholic Acid Tablets Drug Application Not Approved</title></head><body><p><span>Oct 13 (Reuters)</span><span> - </span><a href=\"https://laohu8.com/S/01385\">Shanghai Fudan</a>-Zhangjiang Bio-Pharmaceutical Co Ltd <span>688505.SS</span>:</p><ul><li><p>NEW DRUG APPLICATION FOR OBETICHOLIC ACID TABLETS WAS NOT APPROVED</p></li><li><p>NOTIFICATION RECEIVED FROM NATIONAL MEDICAL PRODUCTS ADMINISTRATION OF PRC</p></li></ul><p>Further company coverage: <span>688505.SS</span></p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK0239","symbol_name":"医药制造","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251013:nFWN3VR2XC:1","article_id":"2575288016","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2575288016","pubTimestamp":1760369461,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"BRIEF-Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Says Obeticholic Acid Tablets Drug Application Not ApprovedOct 13 (Reuters) - Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd 688505.SS:NEW DRUG ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"688505":"复旦张江","BK0239":"医药制造"},"translate_title":"简介-上海复旦张江生物制药称奥贝胆酸片药品申请未获批准","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"688505":0.9},"content_text":"BRIEF-Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Says Obeticholic Acid Tablets Drug Application Not ApprovedOct 13 (Reuters) - Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd 688505.SS:NEW DRUG APPLICATION FOR OBETICHOLIC ACID TABLETS WAS NOT APPROVEDNOTIFICATION RECEIVED FROM NATIONAL MEDICAL PRODUCTS ADMINISTRATION OF PRCFurther company coverage: 688505.SS ((Reuters.Briefs@thomsonreuters.com;))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"productRelease","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2575288016","isCrawlerRequest":true}